玻璃体内注射阿非利西普后早产儿视网膜病变的眼内炎。

IF 0.7 Q4 OPHTHALMOLOGY
Case Reports in Ophthalmological Medicine Pub Date : 2020-12-21 eCollection Date: 2020-01-01 DOI:10.1155/2020/8861435
Elcin Suren, Ersan Cetinkaya, Mustafa Kalayci, Sariye Elif Özyazıcı Özkan, Mehmet Fatih Kucuk, Muhammet Kazim Erol
{"title":"玻璃体内注射阿非利西普后早产儿视网膜病变的眼内炎。","authors":"Elcin Suren,&nbsp;Ersan Cetinkaya,&nbsp;Mustafa Kalayci,&nbsp;Sariye Elif Özyazıcı Özkan,&nbsp;Mehmet Fatih Kucuk,&nbsp;Muhammet Kazim Erol","doi":"10.1155/2020/8861435","DOIUrl":null,"url":null,"abstract":"<p><p>We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred. After two days, despite starting endophthalmitis treatment, there was still no improvement in the retinal lesion. Due to the worsening of the clinical signs, we decided to perform 25-gauge lens-sparing pars plana vitrectomy.</p>","PeriodicalId":9603,"journal":{"name":"Case Reports in Ophthalmological Medicine","volume":"2020 ","pages":"8861435"},"PeriodicalIF":0.7000,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772029/pdf/","citationCount":"4","resultStr":"{\"title\":\"Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection.\",\"authors\":\"Elcin Suren,&nbsp;Ersan Cetinkaya,&nbsp;Mustafa Kalayci,&nbsp;Sariye Elif Özyazıcı Özkan,&nbsp;Mehmet Fatih Kucuk,&nbsp;Muhammet Kazim Erol\",\"doi\":\"10.1155/2020/8861435\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred. After two days, despite starting endophthalmitis treatment, there was still no improvement in the retinal lesion. Due to the worsening of the clinical signs, we decided to perform 25-gauge lens-sparing pars plana vitrectomy.</p>\",\"PeriodicalId\":9603,\"journal\":{\"name\":\"Case Reports in Ophthalmological Medicine\",\"volume\":\"2020 \",\"pages\":\"8861435\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2020-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772029/pdf/\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Ophthalmological Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2020/8861435\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Ophthalmological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8861435","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 4

摘要

我们报告的情况下,男性婴儿谁有玻璃体内抗vegf (afliberept)注射治疗早产儿视网膜病变在月经后35周的年龄。注射后4天,视网膜成像显示黄灰色模糊肿块延伸至右眼玻璃体,玻璃体模糊。两天后,尽管开始眼内炎治疗,视网膜病变仍然没有改善。由于临床症状的恶化,我们决定进行25号保留晶状体的玻璃体切割手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection.

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection.

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection.

We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred. After two days, despite starting endophthalmitis treatment, there was still no improvement in the retinal lesion. Due to the worsening of the clinical signs, we decided to perform 25-gauge lens-sparing pars plana vitrectomy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
38
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信